IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q1 2024 Holdings

Filed 2024-05-15 | 10 holdings | $571.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$142.8M16,390,00025.0%
Biogen Inc(BIIB)COM09062X103$138.7M643,00024.3%
Innoviva Inc(INVA)COM45781M101$110.9M7,277,00019.4%
Gilead Sciences Inc(GILD)COM375558103$80.8M1,103,28214.1%
Neurocrine Biosciences Inc(NBIX)COM64125C109$47.8M346,4268.4%
Amarin Corp PLCSPONS ADR NEW023111206$22.1M24,850,6233.9%
Cytokinetics Inc(CYTK)COM NEW23282W605$21.0M300,0003.7%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$5.6M1,094,1681.0%
VOR Biopharma IncCOM929033108$1.5M618,0000.3%
Regulus Therapeutics Inc(RGLS)COM75915K309$533.3K185,1830.1%